Prothrombotic Activity of Oral Contraceptives in Patients with Congenital Thrombophilia

Abstract

References

1. Girolami A , Tormene D , Vianello F . Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. Clin Appl Thromb Hemost 2001;7:76-76.

2. Mira Y , Aznar J , Estelles A , et al. Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects. Clin Appl Thromb Hemost 2000;6:162-162.

3. Bloemenkamp KWM , Rosendaal FR , Helmerhorst FM , Vandenbroucke JP . Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 2000;160:49-49.

4. Martinelli I , Taioli E , Bucciarelli P , et al. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol 1999;19:700-700.

5. Aznar J , Gilabert J . Oral contraceptive users and screening of factor V Leiden. Thromb Haemost 1999;81:845-845.